6B74
Structures of the two-chain human plasma Factor XIIa co-crystallized with potent inhibitors
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-05-09 |
Detector | RAYONIX MX-300 |
Wavelength(s) | 0.9795 |
Spacegroup name | I 41 |
Unit cell lengths | 80.289, 80.289, 121.731 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 36.215 - 2.323 |
R-factor | 0.1932 |
Rwork | 0.190 |
R-free | 0.22200 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3mfj |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0158) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.400 |
High resolution limit [Å] | 2.320 | 2.320 |
Rmerge | 0.084 | 0.849 |
Number of reflections | 16576 | 1632 |
<I/σ(I)> | 18.19 | 2.98 |
Completeness [%] | 99.9 | 100 |
Redundancy | 6.2 | 6.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 291 | 30 mM HEPES, 0.2 M NH4I, 0.2 M AmSO4 |